Autres langues NeurAxis, Inc.

Actions

NRXS

US64134X2018

Temps Différé Nyse Autres places de cotation 21:04:26 03/06/2024			Varia. 5j.	Varia. 1 janv.
3,17 ^USD	-2,16%		-3,35%	+18,73%

22/05	Neuraxis, Inc. fournit des prévisions de résultats pour la fin de l'année 2024 et l'année 2025	CI
20/05	NeurAxis, Inc. annonce ses résultats pour le premier trimestre terminé le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025	22/05
NeurAxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
NeurAxis, Inc. Terminates Dan Clarence as Chief Operating Officer	16/04
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04
NeurAxis, Inc. Provides Revenue Guidance in Late 2024 and into 2025	09/04
NeurAxis, Inc. Announces IB-Stim Results from A Large, Pediatric, Multi-Center Registry	27/03
Neuraxis, Inc. Appoints Kristin Ferge to the Board	11/03
Top Premarket Decliners	12/02
NeurAxis Names Timothy Henrichs Finance Chief	31/01
NeurAxis, Inc. Announces Resignation of Timothy Henrichs as Independent Director	31/01
NeurAxis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
NeurAxis Signs Option Deal for University of Michigan's Rectal Expulsion Device	08/11
NeurAxis, Inc. Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device	08/11
NeurAxis, Inc. Announces Results of Comparative Study of IB-Stim and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders	26/09/23
NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/09/23
NeurAxis, Inc. Announces Publication of Prospective Study Showing IB-Stim Improves Quality of Life of Adolescents with IBS	12/09/23
Neuraxis, Inc. Highlights Pediatric Post-Concussion Clinical Study	29/08/23
NeurAxis, Inc. has completed an IPO in the amount of $6.592002 million.	08/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT